Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001036446 | SCV001199811 | likely benign | not provided | 2023-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030982 | SCV002683645 | uncertain significance | not specified | 2021-10-14 | criteria provided, single submitter | clinical testing | The c.89-4delG intronic variant, located in intron 2 of the RINT1 gene, results from a deletion of one nucleotide within intron 2 of the RINT1 gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |